Atossa Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Seattle, WA, focused on developing innovative medicines to address significant unmet medical needs in oncology, particularly in the field of breast cancer. The company's primary focus is on the development of their proprietary Z-endoxifen in multiple breast cancer settings, with a mission to transform the breast cancer paradigm by offering advanced prevention and treatment options.
With an experienced leadership team and a commitment to developing novel therapies, Atossa Therapeutics aims to make a meaningful impact in the fight against breast cancer. Through ongoing research and development efforts, including the EVANGELINE study, the company is dedicated to bringing innovative solutions to patients facing this challenging disease.
Generated from the website